XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Kinnate Biopharma Inc. (NASDAQ: KNTE) common stock. Following the closing of the tender offer, XOMA merged Kinnate with and into a subsidiary, XRA 1 Corp. (the “Merger”), and all shares of Kinnate common stock that had not been validly tendered were converted into the right to receive the Offer Price.
Read the full article: XOMA Corporation Announces Closing of Tender Offer //
Source: https://www.globenewswire.com/news-release/2024/04/03/2857002/7281/en/XOMA-Corporation-Announces-Closing-of-Tender-Offer.html